Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,806 | -$2,421 | -$3,308 | -$3,511 |
| Dep. & Amort. | $140 | $118 | $136 | $140 |
| Deferred Tax | $0 | -$250 | $0 | $0 |
| Stock-Based Comp. | $97 | $133 | $150 | $13 |
| Change in WC | $2,047 | -$2,438 | -$1,298 | $262 |
| Other Non-Cash | -$1,782 | -$2,596 | -$487 | $151 |
| Operating Cash Flow | -$3,304 | -$7,454 | -$4,807 | -$2,945 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$9 | $0 | -$22 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$337 | $165 | -$754 | -$263 |
| Investing Cash Flow | -$339 | $156 | -$754 | -$285 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$95 | $245 | -$93 | $0 |
| Stock Issued | $0 | $8,312 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,105 | -$4,645 | $4,738 | $3,974 |
| Financing Cash Flow | $6,010 | $3,912 | $4,645 | $3,974 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,036 | -$5,055 | $5,055 | $372 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | -$458 | $0 | $5,227 |
| End Cash | $4,036 | $1,669 | $5,055 | $372 |
| Free Cash Flow | -$3,306 | -$8,228 | -$4,807 | -$2,967 |